相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRAF Mutations Are Also Associated with Neurocutaneous Melanocytosis and Large/Giant Congenital Melanocytic Nevi
Claudia M. Salgado et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2015)
Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy
Yibing Ruan et al.
NEURO-ONCOLOGY (2015)
Mutations in G Protein Encoding Genes and Chromosomal Alterations in Primary Leptomeningeal Melanocytic Neoplasms
Heidi V. N. Kusters-Vandevelde et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Malignant Melanotic Schwannian Tumor A Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Study of 40 Cases, With a Proposal for the Reclassification of Melanotic Schwannoma
Jorge Torres-Mora et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
GNAQ mutation in a patient with metastatic mucosal melanoma
Chung-Young Kim et al.
BMC CANCER (2014)
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
David N. Louis et al.
BRAIN PATHOLOGY (2014)
Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
M. Dono et al.
BRITISH JOURNAL OF CANCER (2014)
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Fa-Xing Yu et al.
CANCER CELL (2014)
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
Xiaodong Feng et al.
CANCER CELL (2014)
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma A Randomized Clinical Trial
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
BRAF V600E Mutation in Two Distinct Meningeal Melanocytomas Associated With a Nevus of Ota
Lisandra Munoz-Hidalgo et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Frequencies of KIT and GNAQ mutations in acral melanoma
Hanne Eknes Puntervoll et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2014)
Carney complex and McCune Albright syndrome: An overview of clinical manifestations and human molecular genetics
Paraskevi Salpea et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Next generation diagnostic molecular pathology: Critical appraisal of quality assurance in Europe
Hendrikus J. Dubbink et al.
MOLECULAR ONCOLOGY (2014)
Absence of TERT promoter mutations in primary melanocytic tumours of the central nervous system
M. Gessi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2014)
GNAQ and GNA11 mutations in uveal melanoma
Alexander N. Shoushtari et al.
MELANOMA RESEARCH (2014)
Rare SF3B1 R625 mutations in cutaneous melanoma
Yong Kong et al.
MELANOMA RESEARCH (2014)
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations
X. Chen et al.
ONCOGENE (2014)
Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS-mutant melanoma
Vito W. Rebecca et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
Heidi V. N. Kusters-Vandevelde et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis
Francis Shih et al.
Acta Neuropathologica Communications (2014)
Update on molecular pathology of cutaneous melanocytic lesions: What is new in diagnosis and molecular testing for treatment?
Adriana C. H. van Engen-van Grunsven et al.
FRONTIERS IN MEDICINE (2014)
Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11
A. E. Koopmans et al.
BRITISH JOURNAL OF CANCER (2013)
Trametinib: First Global Approval
Cameron J. M. Wright et al.
DRUGS (2013)
Melanocytomas of the Central Nervous System: a clinicopathological and molecular study
Hai Wang et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
Veronica A. Kinsler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma
Wesley O. Greaves et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death
Grazia Ambrosini et al.
MOLECULAR CANCER THERAPEUTICS (2013)
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
Marcel Martin et al.
NATURE GENETICS (2013)
GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system
M. Gessi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas
Hai-Tao Niu et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Psammomatous melanotic schwannoma as indicator of a Carney complex
M. Seidl et al.
PATHOLOGE (2013)
Is it a primary or metastatic melanocytic neoplasm of the central nervous system?: A molecular based approach
Kristine M. Cornejo et al.
PATHOLOGY INTERNATIONAL (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Primary Melanoma of the CNS in Children Is Driven by Congenital Expression of Oncogenic NRAS in Melanocytes
Malin Pedersen et al.
CANCER DISCOVERY (2013)
Christian Posch and Susana Ortiz-Urda
Christian Posch et al.
ONCOTARGET (2013)
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes
Fausto J. Rodriguez et al.
ACTA NEUROPATHOLOGICA (2012)
GNAQ and GNA11 mutations in melanocytomas of the central nervous system
Rajmohan Murali et al.
ACTA NEUROPATHOLOGICA (2012)
Neuropathology of neurocutaneous melanosis: histological foci of melanotic neurones and glia may be undetectable on MRI
Veronica A. Kinsler et al.
ACTA NEUROPATHOLOGICA (2012)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner
Jahan S. Khalili et al.
CLINICAL CANCER RESEARCH (2012)
Identification of Unique MEK-Dependent Genes in GNAQ Mutant Uveal Melanoma Involved in Cell Growth, Tumor Cell Invasion, and MEK Resistance
Grazia Ambrosini et al.
CLINICAL CANCER RESEARCH (2012)
Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
Patrick J. Roberts et al.
CLINICAL CANCER RESEARCH (2012)
Melanocytic tumor with GNA11 p.Q209L mutation mimicking a foramen magnum meningioma
Russell G. Strom et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
Cervical intramedullary melanocytoma: A case report and review of literature
M. Muthappan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines
Erika von Euw et al.
MOLECULAR CANCER (2012)
Protein Kinase C Inhibitor AEB071 Targets Ocular Melanoma Harboring GNAQ Mutations via Effects on the PKC/Erk1/2 and PKC/NF-κB Pathways
Xinqi Wu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma
Xinqi Wu et al.
PLOS ONE (2012)
Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype
Alan L. Ho et al.
PLOS ONE (2012)
Primary leptomeningeal melanocytosis - A case report with an autopsy diagnosis
Zivkovic Nikola et al.
VOJNOSANITETSKI PREGLED (2012)
Proliferative Nodules Arising Within Congenital Melanocytic Nevi: A Histologic, Immunohistochemical, and Molecular Analyses of 43 Cases
Pushkar A. Phadke et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis
J. -H. Lee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
KIT as a Therapeutic Target in Metastatic Melanoma
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Primary Leptomeningeal Melanocytosis in a 10-Year-Old Girl: A Challenging Diagnosis With a Poor Prognosis
Kirsten L. Brunsvig et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Melanotic Choroid Plexus Carcinoma of the Posterior Fossa
Kalpalata Tripathy et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Primary Melanoma of the Spinal Cord: A Case Report, Molecular Footprint, and Review of the Literature
Alexander D. Fuld et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification
Jun Guo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Meningeal melanocytosis: a possibly useful treatment for a rare primary brain neoplasm
Julia Miro et al.
JOURNAL OF NEUROLOGY (2011)
Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 cases
Rupert Langer et al.
MODERN PATHOLOGY (2011)
KIT mutations in ocular melanoma: frequency and anatomic distribution
Michelle L. Wallander et al.
MODERN PATHOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin
David C. Whiteman et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Spinal Meningeal Melanocytoma in the S-1 Nerve Root Sheath with Paraspinal Extension Mimicking Schwannoma
Sang Soo Eun et al.
WORLD NEUROSURGERY (2011)
Genotype-Dependent Sensitivity of Uveal Melanoma Cell Lines to Inhibition of B-Raf, MEK, and Akt Kinases: Rationale for Personalized Therapy
Nicholas Mitsiades et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system
Heidi V. N. Kusters-Vandevelde et al.
ACTA NEUROPATHOLOGICA (2010)
Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis
Heidi V. N. Kusters-Vandevelde et al.
ACTA NEUROPATHOLOGICA (2010)
Clinical and molecular genetics of Carney complex
Anya Rothenbuhler et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Mutations and Polymorphisms in the Gene Encoding Regulatory Subunit Type 1-Alpha of Protein Kinase A (PRKAR1A): An Update
Anelia Horvath et al.
HUMAN MUTATION (2010)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Melanocytes don't always take the high road
Hun-Way Hwang et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Rapid Response to Therapy of Neurocutaneous Melanosis With Leptomeningeal Melanoma
Vivek Subbiah et al.
PEDIATRIC BLOOD & CANCER (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma
J. Bauer et al.
BRITISH JOURNAL OF CANCER (2009)
Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes
Hitomi Aoki et al.
DEVELOPMENT (2009)
Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different Genotypes
Jerome Bertherat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis
Barbara Dessars et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
From the Archives of the AFIP Pigmented Lesions of the Central Nervous System: Radiologic-Pathologic Correlation
Alice Boyd Smith et al.
RADIOGRAPHICS (2009)
KIT Gene Mutations and Copy Number in Melanoma Subtypes
Carol Beadling et al.
CLINICAL CANCER RESEARCH (2008)
The MAPK pathway in melanoma
Leslie A. Fecher et al.
CURRENT OPINION IN ONCOLOGY (2008)
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
Michael D. Onken et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Malignant transformation of spinal meningeal melanocytoma - Case report and review of the literature
Fulin Wang et al.
JOURNAL OF NEUROSURGERY-SPINE (2007)
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations
Juergen Bauer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Detection of BRAF gene mutation in primary choroidal melanoma tissue
G Malaponte et al.
CANCER BIOLOGY & THERAPY (2006)
Cell signalling diversity of the Gqα family of heterotrimeric G proteins
KB Hubbard et al.
CELLULAR SIGNALLING (2006)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Melanoma incidence has risen in Europe
E de Vries et al.
BRITISH MEDICAL JOURNAL (2005)
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
W Zuidervaart et al.
BRITISH JOURNAL OF CANCER (2005)
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background
J Ackermann et al.
CANCER RESEARCH (2005)
Determinants of BRAF mutations in primary melanomas
JL Maldonado et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Meningeal melanocytoma: an aggressive course for a benign tumor
A Bydon et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea
A Weber et al.
LABORATORY INVESTIGATION (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Therapeutic options for meningeal melanocytoma - Case report
D Rades et al.
JOURNAL OF NEUROSURGERY (2001)
Dural melanoma associated with ocular melanosis and multiple blue nevi
JK Rivers et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2001)
Primitive cerebral melanoma: Case report and review of the literature
SG Crasto et al.
SURGICAL NEUROLOGY (2001)
Genomic characterization of the human heterotrimeric G protein α, β, and γ subunit genes
EH Hurowitz et al.
DNA RESEARCH (2000)
分享论文
